Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Large (15.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (14.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (14.5bn) 0 No activity — 0–15%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (14.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (14.0bn) 0 No activity — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (14.0bn) 1–5 $100K–$1M 0–15% 50%+
Pharmaceuticals & Medical Research Large (13.9bn) -6–10 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (13.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (13.5bn) 0 No activity — 0–15%
Healthcare Services Large (13.5bn) 0 No activity — 15–50%
Healthcare Services Large (13.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (13.2bn) 0 No activity — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals & Medical Research Large (13.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 No activity — 50%+
IE ICON PLC (ICLR)
Pharmaceuticals & Medical Research Large (12.9bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 No activity — 0–15%
Healthcare Services Large (12.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.5bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (12.4bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (12.3bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (12.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) 0 No activity — 0–15%
Healthcare Services Large (12.1bn) -1–5 -$10M–$100M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US DaVita Inc (DVA)
Healthcare Services Large (11.7bn) 0 No activity — 15–50%
Healthcare Services Large (11.6bn) 0 No activity — 15–50%
Healthcare Services Large (11.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.6bn) -1–5 -$1M–$10M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.2bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No activity — 0–15%
Healthcare Services Large (10.9bn) 0 No activity — 0–15%
Healthcare Services Large (10.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US Repligen Corp (RGEN)
Healthcare Services Large (10.7bn) 0 No activity — 0–15%
Healthcare Services Large (10.6bn) 0 No activity — 0–15%
Healthcare Services Large (10.6bn) 0 No activity — 0–15%
Healthcare Services Large (10.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.2bn) 0 No activity — 0–15%
Healthcare Services Large (10.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (10.1bn) 0 No activity — 15–50%
AU Cochlear Ltd (COH)
Healthcare Services Large (10.1bn) 0 No activity — 0–15%
US Glaukos Corp (GKOS)
Healthcare Services Large (10.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (10.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.9bn) 0 No activity — 50%+
DK Demant A/S (DEMANT)
Healthcare Services Mid (9.8bn) 0 $100K–$1M 0–15% 50%+
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 No activity — 15–50%
Healthcare Services Mid (9.4bn) 0 No activity — 0–15%
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (9.3bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (9.1bn) 0 No activity — 0–15%
US Insulet Corp (PODD)
Healthcare Services Mid (9.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (8.9bn) 0 No activity — 0–15%
Healthcare Services Mid (8.9bn) -1–5 -$10M–$100M -0–15% 15–50%
US ImmunoGen Inc (IMGN)
Pharmaceuticals & Medical Research Mid (8.7bn) 0 No activity — 0–15%
US Mylan NV (MYL)
Pharmaceuticals & Medical Research Mid (8.6bn) 0 No activity — 0–15%
US Vaxcyte Inc (PCVX)
Pharmaceuticals & Medical Research Mid (8.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Abivax SA (ABVX)
Pharmaceuticals & Medical Research Mid (8.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%
ES Grifols SA (GRF)
Pharmaceuticals & Medical Research Mid (7.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (7.6bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.5bn) 0 No activity — 0–15%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals & Medical Research Mid (7.4bn) 0 No activity — 50%+
Healthcare Services Mid (7.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No activity — 15–50%
Healthcare Services Mid (7.1bn) -1–5 -$100K–$1M -0–15% 50%+
Healthcare Services Mid (7.0bn) 1–5 $10M–$100M 0–15% 50%+
Pharmaceuticals & Medical Research Mid (7.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 0–15%
US Merus NV (MRUS)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 50%+
NL Qiagen NV (QIA)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 0–15%
IE Alkermes Plc (ALKS)
Pharmaceuticals & Medical Research Mid (6.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Medicines Co (MDCO)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — —
US Arcellx, Inc. (ACLX)
Pharmaceuticals & Medical Research Mid (6.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.7bn) 0 No activity — 0–15%
Healthcare Services Mid (6.7bn) -1–5 -$1M–$10M -0–15% 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (6.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (6.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.4bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) -1–5 -$10M–$100M -0–15% 0–15%